Skip to content

Effect of Ingudi Paste and Jatiphala Paste in Vyanga (Melasma)

A Comparative Randomized Clinical trial of Ingudi Lepa and Jatiphala Lepa in the management of Vyanga with special reference to Melasma

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033443
Enrollment
30
Registered
2021-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified Health Condition 2: L819- Disorder of pigmentation, unspecified

Interventions

Intervention1: Ingudi Lepa with water.: In this group patients will be treated with powder of Ingudi phal majja as Lepa (face pack) which will be applied on face with adequate water once a day in morn

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting Vyanga as clinical features according to Susruta Samhita. 2. Patients of either sex. 3. Patients of age between 18 - 60 years.

Exclusion criteria

Exclusion criteria: 1. Melasma due to tubercular therapy or malignant cases. 2. Patients having systemic pathogenesis due to allergy. 3. Patients having diagnosis of major illness like IHD, HTN, MI, TB, COPD, DM etc. would be excluded from trial. 4. Diagnosed patients of Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leucoderma and Leprosy. 5. Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid. 6. Patients of uncontrolled hormonal disease. 7. Any kind of hereditary skin disorder 8. With present history of pregnancy and chronic constipation. 9. Patient suffering from Melasma more than five year. 10. Patients who are reporting allergy history of trail drugs.

Design outcomes

Primary

MeasureTime frame
Reduction in Melasma Area and Severity Index (MASI). in one month ( 4 week)treatmentTimepoint: Reduction in Melasma Area and Severity Index (MASI). in one month ( 4 week) treatment

Secondary

MeasureTime frame
Changes in face skin colour in 4 weeksTimepoint: Changes in face skin colour in 4 weeks

Countries

India

Contacts

Public ContactDr Bhawani Singh Rathore

National Institute of Ayueveda Jaipur

mita@ayu.in9414078872

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026